The NET Alliance is an initiative from Novartis Oncology dedicated to helping improve outcomes in patients with neuroendocrine tumors (NET). It is a long-term commitment to help patients by working with health care providers to advance the diagnosis and support of NET and to educate patients about their disease.
The NET Alliance aims to help patients
Novartis Oncology and Patient Advocacy provide support to patients through an array of programs and services.
The NET Alliance is a Novartis Oncology initiative working to help improve outcomes for patients with NET.